Asia-Pacific journal of clinical oncology
A Japanese Multicenter Database Study of Retroperitoneal Sarcoma: Outcomes of Patients Receiving Eribulin Therapy.
Makito Miyake, Yuki Oda, Nobutaka Nishimura, Motokiyo Yoshikawa, Keiichi Sakamoto, Yoshiaki Matsumura, Atsushi Tomioka, Yusuke Iemura, Masaomi Kuwada, Kota Iida, Takashi Iwamoto, Fumisato Maesaka, Yuta Toyoshima, Tomomi Fujii, Kiyohide Fujimoto
Published: 202610.1111/ajco.70080
Abstract
AIM: Clinical evidence on disease characteristics and outcomes of retroperitoneal sarcoma (RPS) remains limited. Although eribulin was approved for soft tissue sarcomas in Japan in 2016, real-world data on its use for advanced RPS are scarce. We inve…
Preview only. Read the full abstract at the source